CYB5R2
NADH-cytochrome b5 reductase 2
Also known as: NB5R2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6BCY4
- Gene
- CYB5R2
- Ensembl
- ENSG00000166394
- Chromosome
- 11
- Canonical length
- 276 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene belongs to the flavoprotein pyridine nucleotide cytochrome reductase family of proteins. Cytochrome b-type NAD(P)H oxidoreductases are implicated in many processes including cholesterol biosynthesis, fatty acid desaturation and elongation, and respiratory burst in neutrophils and macrophages. Cytochrome b5 reductases have soluble and membrane-bound forms that are the product of alternative splicing. In animal cells, the membrane-bound form binds to the endoplasmic reticulum, where it is a member of a fatty acid desaturation complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
276 residues, UniProt reviewed canonical sequence.
>Q6BCY4|CYB5R2
1 MNSRRREPIT LQDPEAKYPL PLIEKEKISH NTRRFRFGLP SPDHVLGLPV GNYVQLLAKI
61 DNELVVRAYT PVSSDDDRGF VDLIIKIYFK NVHPQYPEGG KMTQYLENMK IGETIFFRGP
121 RGRLFYHGPG NLGIRPDQTS EPKKTLADHL GMIAGGTGIT PMLQLIRHIT KDPSDRTRMS
181 LIFANQTEED ILVRKELEEI ARTHPDQFNL WYTLDRPPIG WKYSSGFVTA DMIKEHLPPP
241 AKSTLILVCG PPPLIQTAAH PNLEKLGYTQ DMIFTYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYB5R2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 129 nTPM
Expression across tissuesHPA
Tissue
- retina: 129 nTPM
- testis: 127 nTPM
- skin: 49 nTPM
- salivary gland: 35 nTPM
- spinal cord: 34 nTPM
- hippocampal formation: 28 nTPM
Single-cell type
- late spermatids: 1,010 nCPM
- late primary spermatocytes: 298 nCPM
- early spermatids: 248 nCPM
- rod photoreceptor cells: 71 nCPM
- schwann cells: 62 nCPM
- esophageal apical cells: 40 nCPM
Immune cell
- memory B-cell: 11 nTPM
- eosinophil: 6.1 nTPM
- naive B-cell: 2.8 nTPM
- classical monocyte: 0.9 nTPM
- total PBMC: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
Brain region
- white matter: 38 nTPM
- basal ganglia: 28 nTPM
- midbrain: 27 nTPM
- thalamus: 25 nTPM
- cerebral cortex: 25 nTPM
- medulla oblongata: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.57
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.28
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cytochrome-b5 reductase activity, acting on NAD(P)H
- cytochrome-b5 reductase activity, acting on NADH
- FAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oxidoreductase FAD/NAD(P)-binding
- Flavoprotein pyridine nucleotide cytochrome reductase
- NADH:cytochrome b5 reductase-like
- Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain
- FAD-binding domain, ferredoxin reductase-type
- Riboflavin synthase-like beta-barrel
- Ferredoxin-NADP reductase (FNR), nucleotide-binding domain
- Oxidoreductase NAD-binding domain
- Oxidoreductase FAD-binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYB5R2 as an antibody target. Whether an autoantibody or antibody against CYB5R2 could matter depends on whether native CYB5R2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYB5R2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYB5R2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...